E-LIB Suche - Ergebnisse für: Huygens, S

1

POSC399 Treatment Effect and Costs of the Complete Therapeu..:

Holleman, MS ; Santi, I ; Huygens, S...
Value in Health. 25 (2022) 1 - p. S266-S267 , 2022

Link: https://doi.org/10.1016/..

2

POSB75 What Is the Net Added Value of Personalised Medicine..:

Vellekoop, H ; Huygens, S ; Versteegh, M...
Value in Health. 25 (2022) 1 - p. S75 , 2022

Link: https://doi.org/10.1016/..

3

PND38 Optimal Treatment Sequence for Relapsing Remitting Mu..:

Versteegh, M. ; Huygens, S. ; Wokke, B..
Value in Health. 23 (2020) - p. S629 , 2020

Link: https://doi.org/10.1016/..

4

PCV92 - EARLY HEALTH TECHNOLOGY ASSESSMENT OF TISSUE-ENGINE..:

Huygens, S. ; Corro Ramos, I. ; Bouten, C....
Value in Health. 21 (2018) - p. S108 , 2018

Link: https://doi.org/10.1016/..

5

COST EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATI..:

Geisler, B.P. ; Osnabrugge, R.L. ; Huygens, S.A....
Value in Health. 19 (2016) 3 - p. A305 , 2016

Link: https://doi.org/10.1016/..

6

Cost-Effectiveness of Including a Nurse Specialist in the T..:

Holtzer-Goor, K. M. ; Gaultney, J. G. ; van Houten, P....
PLOS ONE. 10 (2015) 10 - p. e0138225 , 2015

Link: https://doi.org/10.1371/..

7

Primary sensitization to cinnamyl chloride in an operator o..:

Goossens, A. ; Huygens, S. ; Stoskute, L..
Contact Dermatitis. 55 (2006) 6 - p. 364-365 , 2006

Link: https://doi.org/10.1111/..

8

An update on airborne contact dermatitis:

Huygens, S. ; Goossens, A.
Contact Dermatitis. 44 (2001) 1 - p. 1-6 , 2001

Link: https://doi.org/10.1034/..

9

Budget impact and transferability of cost–effectiveness of ..:

Koleva-Kolarova, R ; Vellekoop, H ; Huygens, S...
doi:10.2217/pme-2022-0133. , 2023

Link: https://doi.org/10.2217/..

10

Financial incentives to promote personalized medicine in Eu..:

Koleva-Kolarova, R ; Szilberhorn, L ; Zelei, T...
doi:10.2217/pme-2022-0145. , 2023

Link: https://doi.org/10.2217/..

11

Cost–effectiveness and budget impact analysis of screening ..:

Szilberhorn, L ; Zelei, T ; Vellekoop, H...
doi:10.2217/pme-2023-0017. , 2023

Link: https://doi.org/10.2217/..

12

Financing and reimbursement models for personalised medicin..:

Koleva-Kolarova, R ; Buchanan, J ; Vellekoop, H...
doi:10.1007/s40258-021-00714-9. , 2022

Link: https://doi.org/10.1007/..

13

Guidance for the harmonisation and improvement of economic ..:

Vellekoop, H ; Huygens, S ; Versteegh, M...
doi:10.1007/s40273-021-01010-z. , 2022

Link: https://doi.org/10.1007/..

14

Cost-effectiveness analysis of treating patients with ntrk-..:

Huygens, S ; Vellekoop, H ; Versteegh, M...
doi:10.1016/j.jval.2022.08.006. , 2022

Link: https://doi.org/10.1016/..

15

Financing and Reimbursement Models for Personalised Medicin..:

Koleva-Kolarova, R ; Buchanan, J ; Vellekoop, H...
APPLIED HEALTH ECONOMICS AND HEALTH POLICY. , 2022

Link: https://qmro.qmul.ac.uk/..